Haematologica, Vol 90, Issue 12, 1665-1671
Copyright © 2005 by Ferrata Storti Foundation
Single-dose pegfilgrastim for the mobilization of allogeneic CD34+ peripheral blood progenitor cells in healthy family and unrelated donors
F Kroschinsky,
K Holig,
K Poppe-Thiede,
K Zimmer,
R Ordemann,
M Blechschmidt,
U Oelschlaegel,
M Bornhauser,
G Rall,
C Rutt,
and
G Ehninger
University Hospital Dresden, 1st Medical Department, Dresden, Germany. kroschinsky@mk1.med.tu-dresden.de
BACKGROUND AND OBJECTIVES: Short-term treatment with granulocyte colony-stimulating factor (G-CSF) has been established as the standard regimen for mobilizing allogeneic peripheral blood progenitor cells (PBPC) from healthy donors. The pegylated form of filgrastim (pegfilgrastim) has a longer elimination half-life because of decreased serum clearance and might be a convenient alternative for stem cell mobilization. DESIGN AND METHODS: Twenty-five family (n=15) or unrelated (n=10) healthy donors received a single-dose of 12 mg pegfilgrastim for mobilization of allogeneic PBPC. Donors with inadequate mobilization (blood CD34+ cells
This article has been cited by other articles:

|
 |

|
 |
 
S. R. Larsen, K. Chng, F. Battah, R. Martiniello-Wilks, and J. E.J. Rasko
Improved Granulocyte Colony-Stimulating Factor Mobilization of Hemopoietic Progenitors Using Cytokine Combinations in Primates
Stem Cells,
November 1, 2008;
26(11):
2974 - 2980.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. M. Lemoli and A. D'Addio
Hematopoietic stem cell mobilization
Haematologica,
March 1, 2008;
93(3):
321 - 324.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Russell, R. Mesters, J. Schubert, M. Boogaerts, H. E. Johnsen, C. d. Canizo, N. Baker, P. Barker, T. Skacel, and N. Schmitz
A phase 2 pilot study of pegfilgrastim and filgrastim for mobilizing peripheral blood progenitor cells in patients with non-Hodgkin's lymphoma receiving chemotherapy
Haematologica,
March 1, 2008;
93(3):
405 - 412.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2005 by the Ferrata Storti Foundation.